Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis. J of Skin [Internet]. 2023 Nov. 13 [cited 2026 Apr. 16];7(6):s276. Available from: https://skin.dermsquared.com/skin/article/view/2386